Jailani, Jernalyn I.
HRN: 20-61-40 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/10/2023
GENTAMICIN 40MG/ML, 2ML (AMP)
02/10/2023
02/16/2023
IV
23
ONCE DAILY
PNEUMONIA
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes